Loading organizations...
§ Venture Capital · Helsinki, Finland
An organization for which specific details about its operations, services, and target markets are not publicly available.
Biothom is a Helsinki-based venture capital firm providing strategic capital and investment support to early-stage life science companies. Its core offering identifies promising ventures in medical technology and biotechnology, supplying financial impetus for their development. The firm’s capabilities include rigorous due diligence and active portfolio management, positioning investments for growth.
Established in 1989 in Helsinki, Finland, Biothom was founded on the insight that emerging life science companies required specialized financial backing. This vision recognized the long-term value in supporting groundbreaking scientific research and translating into tangible healthcare benefits. The firm aimed to bridge the funding gap for pioneering ventures across the Nordic region and United States.
Innovative life science and biotechnology startups across Sweden, Finland, and the United States utilize Biothom’s investment platform. The firm’s long-term vision is to be a catalyst for medical innovation, fostering the growth of companies developing advanced therapies, diagnostics, and devices. Biothom seeks to accelerate progress in human health by empowering visionary entrepreneurs.
Biothom has 1 tracked investment across 1 company. The latest tracked deal is $11.7M Series B in Mendor in June 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 22, 2011 | Mendor | $11.7M Series B | Risto Siilasmaa | Finnvera, Ilmarinen, Anne Portwich, Tesi |